Werewolf Therapeutics, Inc. (HOWL)
NASDAQ: HOWL · Real-Time Price · USD
0.6345
-0.0276 (-4.17%)
Feb 4, 2026, 10:36 AM EST - Market open
Werewolf Therapeutics Market Cap
Werewolf Therapeutics has a market cap or net worth of $30.8 million as of February 4, 2026. Its market cap has decreased by -48.04% in one year.
Market Cap
30.80M
Enterprise Value
3.73M
1-Year Change
-48.04%
Ranking
Category
Stock Price
$0.63
Market Cap Chart
Since the IPO on April 30, 2021, Werewolf Therapeutics's market cap has decreased from $440.42M to $30.80M, a decrease of -93.01%. That is a compound annual growth rate of -42.77%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 3, 2026 | 32.14M | 4.51% |
| Dec 31, 2025 | 30.75M | -53.38% |
| Dec 31, 2024 | 65.95M | -52.79% |
| Dec 29, 2023 | 139.70M | 121.66% |
| Dec 30, 2022 | 63.03M | -80.81% |
| Dec 31, 2021 | 328.47M | -25.42% |
| Apr 30, 2021 | 440.42M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Reviva Pharmaceuticals Holdings | 34.17M |
| TuHURA Biosciences | 32.49M |
| Lixte Biotechnology Holdings | 32.41M |
| Skye Bioscience | 32.38M |
| Outlook Therapeutics | 32.32M |
| Kyntra Bio | 31.88M |
| Dyadic International | 31.52M |
| AN2 Therapeutics | 30.96M |